An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.
Several experts stated the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.
Platform Response and Material Removal
Based on the social media company, the service has taken down violative content and prohibited associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Online Trading Operations
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.
After moments of entering one group, a vendor shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Product Details and Pricing
Inside these communities, messages show black plastic packages with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A spokesperson for Telegram stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they cannot confirm. Although the science behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may subject patients to possibly significant medical dangers”.
